These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 24477798)

  • 1. Serious transport accidents in adults with attention-deficit/hyperactivity disorder and the effect of medication: a population-based study.
    Chang Z; Lichtenstein P; D'Onofrio BM; Sjölander A; Larsson H
    JAMA Psychiatry; 2014 Mar; 71(3):319-25. PubMed ID: 24477798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of psychiatric comorbidities with the risk of transport accidents in ADHD and MPH.
    Liu YC; Chen VC; Yang YH; Chen YL; Gossop M
    Epidemiol Psychiatr Sci; 2021 Feb; 30():e14. PubMed ID: 33583471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Medication Use for Attention-Deficit/Hyperactivity Disorder and Risk of Motor Vehicle Crashes.
    Chang Z; Quinn PD; Hur K; Gibbons RD; Sjölander A; Larsson H; D'Onofrio BM
    JAMA Psychiatry; 2017 Jun; 74(6):597-603. PubMed ID: 28492937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Psychiatric Comorbidity With the Risk of Premature Death Among Children and Adults With Attention-Deficit/Hyperactivity Disorder.
    Sun S; Kuja-Halkola R; Faraone SV; D'Onofrio BM; Dalsgaard S; Chang Z; Larsson H
    JAMA Psychiatry; 2019 Nov; 76(11):1141-1149. PubMed ID: 31389973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medication for attention deficit-hyperactivity disorder and criminality.
    Lichtenstein P; Halldner L; Zetterqvist J; Sjölander A; Serlachius E; Fazel S; Långström N; Larsson H
    N Engl J Med; 2012 Nov; 367(21):2006-14. PubMed ID: 23171097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medication treatment for attention-deficit/hyperactivity disorder and the risk of acute seizures in individuals with epilepsy.
    Brikell I; Chen Q; Kuja-Halkola R; D'Onofrio BM; Wiggs KK; Lichtenstein P; Almqvist C; Quinn PD; Chang Z; Larsson H
    Epilepsia; 2019 Feb; 60(2):284-293. PubMed ID: 30682219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medication for Attention-Deficit/Hyperactivity Disorder and Risk for Depression: A Nationwide Longitudinal Cohort Study.
    Chang Z; D'Onofrio BM; Quinn PD; Lichtenstein P; Larsson H
    Biol Psychiatry; 2016 Dec; 80(12):916-922. PubMed ID: 27086545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Motor Vehicle Crash Risk Among Adolescents and Young Adults With Attention-Deficit/Hyperactivity Disorder.
    Curry AE; Metzger KB; Pfeiffer MR; Elliott MR; Winston FK; Power TJ
    JAMA Pediatr; 2017 Aug; 171(8):756-763. PubMed ID: 28604931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of medication for attention-deficit/hyperactivity disorder and risk of unintentional injuries in children and adolescents with co-occurring neurodevelopmental disorders.
    Ghirardi L; Chen Q; Chang Z; Kuja-Halkola R; Skoglund C; Quinn PD; D'Onofrio BM; Larsson H
    J Child Psychol Psychiatry; 2020 Feb; 61(2):140-147. PubMed ID: 31625605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attention-deficit/hyperactivity disorder and risk for drug use disorder: a population-based follow-up and co-relative study.
    Sundquist J; Ohlsson H; Sundquist K; Kendler KS
    Psychol Med; 2015 Apr; 45(5):977-83. PubMed ID: 25119068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Pharmacological Treatment of Attention-Deficit/Hyperactivity Disorder and Long-term Unemployment Among Working-Age Individuals in Sweden.
    Li L; Chang Z; Sun J; Jangmo A; Zhang L; Andersson LM; Werner-Kiechle T; Ahnemark E; D'Onofrio BM; Larsson H
    JAMA Netw Open; 2022 Apr; 5(4):e226815. PubMed ID: 35476068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Attention-Deficit/Hyperactivity Disorder With Teenage Birth Among Women and Girls in Sweden.
    Skoglund C; Kopp Kallner H; Skalkidou A; Wikström AK; Lundin C; Hesselman S; Wikman A; Sundström Poromaa I
    JAMA Netw Open; 2019 Oct; 2(10):e1912463. PubMed ID: 31577361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common etiological factors of attention-deficit/hyperactivity disorder and suicidal behavior: a population-based study in Sweden.
    Ljung T; Chen Q; Lichtenstein P; Larsson H
    JAMA Psychiatry; 2014 Aug; 71(8):958-64. PubMed ID: 24964928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The increased risk of road crashes in attention deficit hyperactivity disorder (ADHD) adult drivers: driven by distraction? Results from a responsibility case-control study.
    El Farouki K; Lagarde E; Orriols L; Bouvard MP; Contrand B; Galéra C
    PLoS One; 2014; 9(12):e115002. PubMed ID: 25536069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attention-Deficit/Hyperactivity Disorder Medications and Long-Term Risk of Cardiovascular Diseases.
    Zhang L; Li L; Andell P; Garcia-Argibay M; Quinn PD; D'Onofrio BM; Brikell I; Kuja-Halkola R; Lichtenstein P; Johnell K; Larsson H; Chang Z
    JAMA Psychiatry; 2024 Feb; 81(2):178-187. PubMed ID: 37991787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of asthma medication and familial factors on the association between childhood asthma and attention-deficit/hyperactivity disorder: a combined twin- and register-based study: Epidemiology of Allergic Disease.
    Holmberg K; Lundholm C; Anckarsäter H; Larsson H; Almqvist C
    Clin Exp Allergy; 2015 May; 45(5):964-973. PubMed ID: 25772649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attention-Deficit/Hyperactivity Disorder and Mortality Risk in Taiwan.
    Chen VC; Chan HL; Wu SI; Lee M; Lu ML; Liang HY; Dewey ME; Stewart R; Lee CT
    JAMA Netw Open; 2019 Aug; 2(8):e198714. PubMed ID: 31390039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serious Transport Accidents in Tourette Syndrome or Chronic Tic Disorder.
    Mataix-Cols D; Brander G; Chang Z; Larsson H; D'Onofrio BM; Lichtenstein P; Sidorchuk A; Fernández de la Cruz L
    Mov Disord; 2021 Jan; 36(1):188-195. PubMed ID: 32969536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attention deficit hyperactivity disorder, other mental health problems, substance use, and driving: examination of a population-based, representative canadian sample.
    Vingilis E; Mann RE; Erickson P; Toplak M; Kolla NJ; Seeley J; Jain U
    Traffic Inj Prev; 2014; 15 Suppl 1():S1-9. PubMed ID: 25307372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of accidents and unintentional injuries in men and women with attention deficit hyperactivity disorder across the adult lifespan.
    Libutzki B; Neukirch B; Kittel-Schneider S; Reif A; Hartman CA
    Acta Psychiatr Scand; 2023 Feb; 147(2):145-154. PubMed ID: 36464800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.